Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Daniela Budiu"'
Autor:
Nasser Lakkis, David J. Cohen, David A. Morrow, C. Michael Gibson, Theresa M. Palabrica, Sabina A. Murphy, Daniela Budiu, Ajay J. Kirtane, Howard C. Herrmann, Eric D. Peterson, Gregory Piazza
Publikováno v:
Journal of the American College of Cardiology. 47:2374-2379
Objectives We aimed to identify correlates of Thrombolysis In Mycocardial Infarction (TIMI) major/minor bleeding among eptifibatide-treated patients undergoing percutaneous coronary intervention (PCI). Background Evaluation of bleeding predictors amo
Autor:
Theresa M. Palabrica, Ajay J. Kirtane, Nasser Lakkis, David J. Cohen, Daniela Budiu, James C. Blankenship, Henry H. Lui, Sabina A. Murphy, C. Michael Gibson, Howard C. Herrmann, Lisa K. Jennings, Dimitri Karmpaliotis, Ioanna Kosmidou, William J. French, Richard Kovach, Kausik K. Ray, David A. Morrow
Publikováno v:
The American Journal of Cardiology. 97:1473-1477
Drug-eluting stents (DESs) deliver biphasic (early and late) elution of anti-inflammatory compounds. We therefore hypothesized that DESs would be associated with early reductions in inflammatory biomarker release after percutaneous coronary intervent
Autor:
David Goukassian, Sharath Sasi, Juyong Lee, James R Stone, Daniela Budiu, Christopher Lawson, Michael Maysky, Lynn Hlatky, Joseph Carrozza, James P Morgan, Giannoula Klement, Xinhua Yan
Publikováno v:
Circulation Research. 109
Background: Clinical studies showed that Trastuzumab, a monoclonal antibody that blocks the HER2 receptor, exacerbated chemotherapy drug doxorubicin (DOX)-induced heart failure. Lapatinib, a small molecule inhibitor of HER2 and EGF receptor (EGFR), i
Autor:
Ajay J, Kirtane, Gregory, Piazza, Sabina A, Murphy, Daniela, Budiu, David A, Morrow, David J, Cohen, Eric, Peterson, Nasser, Lakkis, Howard C, Herrmann, Theresa M, Palabrica, C Michael, Gibson
Publikováno v:
Journal of the American College of Cardiology. 47(12)
We aimed to identify correlates of Thrombolysis In Mycocardial Infarction (TIMI) major/minor bleeding among eptifibatide-treated patients undergoing percutaneous coronary intervention (PCI).Evaluation of bleeding predictors among patients treated wit
Autor:
Daniela Budiu, Anh B. Bui, Robert P. Giugliano, Ajay J. Kirtane, Sabina A. Murphy, Christopher P. Cannon, Julian M. Aroesty, Eugene Braunwald, Ioanna Kosmidou, Elliot M Antman, Aaron Weisbord, C. Michael Gibson, Dimitrios Karmpaliotis
Publikováno v:
Journal of the American College of Cardiology. 43(5)
Autor:
Elliot M Antman, Sabina A. Murphy, Ioanna Kosmidou, Dimitrios Karmpaliotis, Christopher P. Cannon, C. Michael Gibson, Dan Guerra, Ajay J. Kirtane, Daniela Budiu, Robert P. Giugliano, Eugene Braunwald
Publikováno v:
Journal of the American College of Cardiology. 43(5):A261-A262
Autor:
Sharath P. Sasi, Joseph P. Carrozza, James P. Morgan, Christopher Lawson, Daniela Budiu, Lynn Hlatky, Xinhua Yan, Michael Maysky, Juyong Lee, David A. Goukassian
Publikováno v:
Cancer Research. 71:1209-1209
Background: Concurrent use of chemotherapy drug doxorubicin (DOX) and Trastuzumab, a monocloncal antibody that blocks HER2, induced cardiac dysfunction in 27% of patients. Clinical trials have shown that the incidence of symptomatic heart failure was